BYLVAY

medison pharma canada inc.🇨🇦 Health Canada

Approval Id: c19b5f74bedb188a
Drug Approval Canada Name: BYLVAY
Product Name: BYLVAY
Status: Marketed
Status Date: 2024-02-07
Original Market Date: 2024-02-07
Din: 02542641
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 56:92.00
Atc Original: A05AX05 ODEVIXIBAT
Atc Name: a 05 ax 05
Aig Number: 0165181001
Company Name: medison pharma canada inc.
Company Address: 400-154 University Avenue, Toronto, Ontario, Canada, M5H 3Y9

ODEVIXIBAT

200 MCG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c19b5f74bedb188a

Type

Standard